P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA

P505：GIMEMA AML1819 试验：吉妥珠单抗奥佐加米星联合强化化疗对急性髓系白血病巩固治疗后可测量残留病灶 (MRD) 水平的影响

阅读：1
作者：Li,Yonghui,Dou,Liping,Nervi,Clara,Péterffy,Borbála,Krizsán,Szilvia,Egyed,Bálint,Bedics,Gábor,Bekő,Anna,Erdélyi,Dániel János,Müller,Judit,Nagy,Tibor,Hegyi,Lajos László,Jakab,Zsuzsanna,Péter,György,Zombori,Marianna,Csanádi,Krisztina,Ottóffy,Gábor,Csernus,Katalin,Vojcek,Ágnes,Tiszlavicz,Lilla Györgyi,Gábor,Krisztina Míta,Kelemen,Ágnes,Hauser,Péter,Kállay,Krisztián,Kertész,Gabriella,Gaál,Zsuzsanna,Szegedi,István,Márk,Ágnes,Haltrich,Irén,Hevessy,Zsuzsanna,Ujfalusi,Anikó,Kajtár,Béla,Kiss,Csongor,Kriván,Gergely,Matolcsy,András,Kovács,Gábor,Bödör,Csaba,Alpár,Donát,Matsuo,Hidemasa,Yoshida,Kenichi,Nannya,Yasuhito,Ito,Yuri,Inagami,Aina,Ito,Nana,Iyoda,Shinju,Saito,Shoji,Koga,Yuhki,Moritake,Hiroshi,Terui,Kiminori,Kawaguchi,Koji,Okamoto,Yasuhiro,Nakayama,Hideki,Kanno,Miyako,Hino,Moeko,Akane,Yusuke,Inoue,Akiko,Shimada,Akira,Goto,Hiroaki,Ueno,Hiroo,Takita,Junko,Yamato,Genki,Shiba,Norio,Hayashi,Yasuhide,Shiraishi,Yuichi,Miyano,Satoru,Kiyokawa,Nobutaka,Tomizawa,Daisuke,Taga,Takashi,Tawa,Akio,Ogawa,Seishi,Adachi,Souichi,Venditti,Adriano,Piciocchi,Alfonso,Maurillo,Luca,Ilaria Del Principe,Maria,Palmieri,Raffaele,Soddu,Stefano,Moretti,Federico,Salutari,Prassede,Martelli,Maurizio,Paola Martelli,Maria,Luppi,Mario,Pulsoni,Alessandro,Zaja,Francesco,Cairoli,Roberto,Pane,Fabrizio,Siragusa,Sergio,Bassan,Renato,Rondoni,Michela,Mirabile,Milena,Mulè,Antonino,Beltrami,Germana,Zappasodi,Patrizia,Cudillo,Laura,Mengarelli,Andrea,Curti,Antonio,Ferrara,Felicetto,Rossi,Giovanni,Audisio,Ernesta,Spinosa,Giuseppina,Tieghi,Alessia,Bocchia,Monica,Martini,Vincenza,Califano,Catello,Rigacci,Luigi,Tafuri,Agostino,Gottardi,Michele,Fazi,Paola,Vignetti,Marco,Buccisano,Francesco
期刊：Frontiers in Oncology影响因子：3.300
时间：2023起止号：2023 Aug;7(Suppl):1275992
doi：10.3389/fonc.2023.1275992疾病类型： 白血病

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。